Works matching IS 11732563 AND DT 2009 AND VI 29 AND IP 12


Results: 7
    1

    Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer: An Open-Label, Non-Comparative, Multicentre, Phase III Study.

    Published in:
    Clinical Drug Investigation, 2009, v. 29, n. 12, p. 757, doi. 10.2165/11319690-000000000-00000
    By:
    • Lundström, Eija A.;
    • Rencken, Rupert K.;
    • van Wyk, Johann H.;
    • Coetzee, Lance J. E.;
    • Bahlmann, Johann C. M.;
    • Reif, Simon;
    • Strasheim, Erdam A.;
    • Bigalke, Martin C.;
    • Pontin, Alan R.;
    • Goedhals, Louis;
    • Steyn, Douw G.;
    • Heyns, Chris F.;
    • Aldera, Luigi A.;
    • Mackenzie, Thomas M.;
    • Purcea, Daniela;
    • Grosgurin, Pierre Y.;
    • Porchet, Hervé C.
    Publication type:
    Article
    2
    3

    Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

    Published in:
    Clinical Drug Investigation, 2009, v. 29, n. 12, p. 777, doi. 10.2165/11530800-000000000-00000
    By:
    • Stauffer, Joseph;
    • Setnik, Beatrice;
    • Sokolowska, Marta;
    • Romach, Myroslava;
    • Johnson, Franklin;
    • Sellers, Edward
    Publication type:
    Article
    4
    5

    Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

    Published in:
    Clinical Drug Investigation, 2009, v. 29, n. 12, p. 811, doi. 10.2165/11530610-000000000-00000
    By:
    • Yajima, Ken;
    • Shimada, Akira;
    • Hirose, Hiroshi;
    • Oikawa, Yoichi;
    • Yamada, Satoru;
    • Meguro, Shu;
    • Irie, Junichiro;
    • Irie, Seiko
    Publication type:
    Article
    6
    7